These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 2310763)

  • 1. Competitive inhibition of lipolytic enzymes. III. Some acylamino analogues of phospholipids are potent competitive inhibitors of porcine pancreatic phospholipase A2.
    de Haas GH; Dijkman R; van Oort MG; Verger R
    Biochim Biophys Acta; 1990 Mar; 1043(1):75-82. PubMed ID: 2310763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competitive inhibition of lipolytic enzymes. IV. Structural details of acylamino phospholipid analogues important for the potent inhibitory effects on pancreatic phospholipase A2.
    de Haas GH; Dijkman R; Ransac S; Verger R
    Biochim Biophys Acta; 1990 Oct; 1046(3):249-57. PubMed ID: 2171669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competitive inhibition of lipolytic enzymes. IX. A comparative study on the inhibition of pancreatic phospholipases A2 from different sources by (R)-2-acylamino phospholipid analogues.
    de Haas GH; Dijkman R; Lugtigheid RB; Dekker N; Van den Berg L; Egmond MR; Verheij HM
    Biochim Biophys Acta; 1993 Apr; 1167(3):281-8. PubMed ID: 8481389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competitive inhibition of lipolytic enzymes. V. A monolayer study using enantiomeric acylamino analogues of phospholipids as potent competitive inhibitors of porcine pancreatic phospholipase A2.
    Ransac S; Deveer AM; Rivière C; Slotboom AJ; Gancet C; Verger R; De Haas GH
    Biochim Biophys Acta; 1992 Jan; 1123(1):92-100. PubMed ID: 1730050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competitive inhibition of lipolytic enzymes. VII. The interaction of pancreatic phospholipase A2 with micellar lipid/water interfaces of competitive inhibitors.
    Deveer AM; Franken PA; Dijkman R; Meeldijk J; Egmond MR; Verheij HM; Verger R; de Haas GH
    Biochim Biophys Acta; 1992 Apr; 1125(1):73-81. PubMed ID: 1567910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Competitive inhibition of lipolytic enzymes. X. Further delineation of the active site of pancreatic phospholipases A2 from pig, ox and horse by comparing the inhibitory power of a number of (R)-2-acylamino phospholipid analogues.
    Dijkman R; Cox R; van den Berg L; Verheij HM; De Haas GH
    Biochim Biophys Acta; 1994 Apr; 1212(1):50-8. PubMed ID: 8155726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competitive inhibition of lipolytic enzymes. XI. Estimation of the interfacial dissociation constants of porcine pancreatic phospholipase A2 for substrate and inhibitor in the absence of detergents.
    De Haas GH; Dijkman R; Boots JW; Verheij HM
    Biochim Biophys Acta; 1995 Jul; 1257(2):87-95. PubMed ID: 7619862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Competitive inhibition of lipolytic enzymes. VI. Inhibition of two human phospholipases A2 by acylamino phospholipid analogues.
    van den Berg L; Franken PA; Verheij HM; Dijkman R; de Haas GH
    Biochim Biophys Acta; 1992 Feb; 1124(1):66-70. PubMed ID: 1543727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural importance of the amino-terminal residue of pancreatic phospholipase A2.
    van Scharrenburg GJ; Jansen EH; Egmond MR; de Haas GH; Slotboom AJ
    Biochemistry; 1984 Dec; 23(25):6285-94. PubMed ID: 6441599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interaction of phospholipase A2 with phospholipid analogues and inhibitors.
    Yu L; Deems RA; Hajdu J; Dennis EA
    J Biol Chem; 1990 Feb; 265(5):2657-64. PubMed ID: 2303420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic and inhibition studies of phospholipase A2 with short-chain substrates and inhibitors.
    Yuan W; Quinn DM; Sigler PB; Gelb MH
    Biochemistry; 1990 Jun; 29(25):6082-94. PubMed ID: 2383571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competitive inhibition of lipolytic enzymes. VIII: Inhibitor-induced aggregation of porcine pancreatic phospholipase A2.
    Deveer AM; den Ouden AT; Vincent M; Gallay J; Verger R; Egmond MR; Verheij HM; de Haas GH
    Biochim Biophys Acta; 1992 Jun; 1126(1):95-104. PubMed ID: 1606180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of porcine pancreatic phospholipase A2 to various micellar substrate analogues. Involvement of histidine-48 and aspartic acid-49 in the binding process.
    Donné-Op den Kelder GM; Hille JD; Dijkman R; de Haas GH; Egmond MR
    Biochemistry; 1981 Jul; 20(14):4074-8. PubMed ID: 7284311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipase A2 inhibitors: monoacyl, monoacylamino-glycero-phosphocholines.
    De Haas GH; van Oort MG; Dijkman R; Verger R
    Biochem Soc Trans; 1989 Apr; 17(2):274-6. PubMed ID: 2753202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activities of native and tyrosine-69 mutant phospholipases A2 on phospholipid analogues. A reevaluation of the minimal substrate requirements.
    Kuipers OP; Dekker N; Verheij HM; de Haas GH
    Biochemistry; 1990 Jun; 29(25):6094-102. PubMed ID: 2116905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An affinity column for phospholipase A2 based on immobilised acylaminophospholipid analogues.
    Dijkman R; Beiboer SH; Verheij HM
    Biochim Biophys Acta; 1997 Jul; 1347(1):1-8. PubMed ID: 9233682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for the involvement of tyrosine-69 in the control of stereospecificity of porcine pancreatic phospholipase A2.
    Kuipers OP; Dijkman R; Pals CE; Verheij HM; de Haas GH
    Protein Eng; 1989 Mar; 2(6):467-71. PubMed ID: 2710783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of phospholipase A2 by "lipocortins" and calpactins. An effect of binding to substrate phospholipids.
    Davidson FF; Dennis EA; Powell M; Glenney JR
    J Biol Chem; 1987 Feb; 262(4):1698-705. PubMed ID: 2948959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMR studies of interactions between inhibitors and porcine pancreatic phospholipase A2.
    Peters AR; Dekker N; van den Berg L; Boelens R; Slotboom AJ; de Haas GH; Kaptein R
    Biochimie; 1992; 74(9-10):859-66. PubMed ID: 1467344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and characterization of a mutant human platelet phospholipase A2 expressed in Escherichia coli. Cleavage of a fusion protein with cyanogen bromide.
    Franken PA; Van den Berg L; Huang J; Gunyuzlu P; Lugtigheid RB; Verheij HM; De Haas GH
    Eur J Biochem; 1992 Jan; 203(1-2):89-98. PubMed ID: 1730245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.